ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CHT Constellation Healthcare Technologies

216.00
0.00 (0.00%)
08 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Constellation Healthcare Technologies LSE:CHT London Ordinary Share CMN SHS USD0.0001 (DI/REG S)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 216.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Constellation Healthcare Tech, Inc Result of General Meeting (4886U)

18/01/2017 12:16pm

UK Regulatory


Constellation Healthcare (LSE:CHT)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Constellation Healthcare Charts.

TIDMCHT

RNS Number : 4886U

Constellation Healthcare Tech, Inc

18 January 2017

18 January 2017

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

RECOMMENDED ACQUISITION

of

Constellation Healthcare Technologies, Inc. (the "Company")

by a subsidiary of CHT Holdco, LLC

to be effected by means of a merger under the laws of the State of Delaware (the "Acquisition")

Result of General Meeting

Further to the publication of the Proxy Statement by Constellation Healthcare Technologies, Inc. on 28(th) December 2016 (the "Proxy Statement"), the Company announces that the following resolution was passed at the Company's General Meeting held this morning, 18(th) January 2017. The resolution was duly passed on a poll.

For information, the votes cast were as follows:

 
 Resolution          For           % voting   Against   % voting   Total         Vote 
                                    rights               rights     Votes         Withheld 
                                                                    Cast 
                                                                    (excl. 
                                                                    Votes 
                                                                    withheld) 
------------------  ------------  ---------  --------  ---------  ------------  ---------- 
 To approve 
  the Acquisition 
  and the terms 
  of the Merger 
  Agreement           86,763,900    94.22%     75,851    0.08%      86,839,751    zero 
------------------  ------------  ---------  --------  ---------  ------------  ---------- 
 

The proxy figures for the resolution will also be displayed on the Company's website at http://www.constellationhealthgroup.com.

Pursuant to the timetable set out in the Proxy Statement the Acquisition is expected to complete on 26(th) January 2017, subject to satisfaction or waiver of other conditions to closing as provided for in the Merger Agreement and as disclosed in the Proxy Statement. Cancellation of admission of the Common Shares to trading on AIM will be effective on 27 January 2017 and the Receiving Agent will commence payment of the Acquisition Price to Shareholders on the same day.

To the extent that Shareholders have yet to complete and return the Form of Declarations, the appropriate Tax Forms and the Delaware Voting Agreement (which notwithstanding the fact that the General Meeting has now taken place is still relevant as it contains a waiver of claims under Delaware law and the execution of which will entitle Shareholders to receive A Promissory Notes which may have a higher value than the B Promissory Notes) in accordance with the instructions set out in the Proxy Statement under the heading "Action to be Taken" they are strongly encouraged to do so by no later than 26(th) January 2017.

Unless otherwise provided, capitalised terms used but not otherwise defined in this announcement shall have the meanings set out in the Proxy Statement.

Enquiries:

CC Capital Management, LLC

   Doug Newton                                                                 newton@cc.capital 

Finsbury - PR adviser to CC Capital

   Charles O'Brien  (UK)                                                     Tel: +44 20 7251 3801 

charles.obrien@finsbury.com

   Kal Goldberg (US)                                                          Tel: +1 646 805 2005 

kal.goldberg@finsbury.com

   Chris Ryall (U.S.)                                                           Tel: +1 646 805 2078 

chris.ryall@finsbury.com

Constellation Healthcare Technologies, Inc.

   Paul Parmar, Chief Executive Officer                                c/o Redleaf Communications 
   Sotirios ("Sam") Zaharis, Chief Financial Officer               Tel: +44 20 7382 4730 

finnCap Tel: +44 20 7220 0500

   Stuart Andrews / Julian Blunt / Scott Mathieson               Corporate Finance 
   Simon Johnson                                                              Corporate Broking 
   Redleaf Communications - PR adviser to CHT                   Tel: +44 20 7382 4730 
   Charlie Geller / Sam Modlin                                            constellation@redleafpr.com 

This information is provided by RNS

The company news service from the London Stock Exchange

END

ROMLVLFFDFFFBBL

(END) Dow Jones Newswires

January 18, 2017 07:16 ET (12:16 GMT)

1 Year Constellation Healthcare Chart

1 Year Constellation Healthcare Chart

1 Month Constellation Healthcare Chart

1 Month Constellation Healthcare Chart

Your Recent History

Delayed Upgrade Clock